Metoprolol and Trimetazidine for Coronary Heart Disease With Angina

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2025
This is a prospective, randomized study to evaluate the effectiveness and safety of combining metoprolol succinate with trimetazidine compared to standard therapy for patients with coronary heart disease (CHD) and angina pectoris. The study aims to assess the effects of the combination therapy on inflammatory biomarkers, clinical efficacy, angina symptoms, and left ventricular function over a 3-month treatment-period.
Epistemonikos ID: bc6fdcd0cca278958f574577431d475a114251f7
First added on: Jul 22, 2025